ATR and prostate carcinoma: For example, phosphorylation of RRM1 regulates DNA replication and ATR inhibition vulnerability, while RRM2 drives aggressive prostate cancer and hepatocellular carcinoma, suggesting their importance for targeted therapies 38,39.